七氟烷复合丙泊酚控制性降压用于动脉瘤介入栓塞手术的临床分析  

Seven isoflurane combined with propofol controlled hypotension for clinical analysis of interventional embolization of aneurysm surgery

在线阅读下载全文

作  者:张碧欣[1] 杨帅[1] 何斌[1] 华丽[1] 

机构地区:[1]成都大学附属医院麻醉科,四川成都610000

出  处:《中西医结合心血管病电子杂志》2015年第29期1-2,共2页Cardiovascular Disease Electronic Journal of Integrated Traditional Chinese and Western Medicine

摘  要:目的探讨七氟烷复合丙泊酚用于动脉瘤介入栓塞手术中控制性降压的效果。方法选取我院2014年2月~2015年2月收治的动脉瘤患者60例为研究对象,均需要接受动脉瘤介入栓塞手术。将其随机分为观察组和对照组,各30例。观察组患者吸入七氟烷复合丙泊酚,对照组患者单纯吸入七氟烷。观察患者血氧饱和度(Sp O2)、心率(HR)、平均动脉压(MAP)及控制性降压过程中的心电图变化情况,记录患者体内七氟烷的浓度、麻醉药物持续时间、拔管时间、低血压、术后躁动症发生率。结果两组患者Sp O2、HR、MAP、麻醉药物持续时间、拔管时间比较,差异无统计学意义(P〉0.05);观察组患者体内七氟烷的浓度、低血压及术后躁动症发生率明显低于对照组,差异有统计学意义(P〈0.05)。结论七氟烷复合丙泊酚用于动脉瘤介入栓塞手术中的控制性降压的效果较好,值得临床大力推广。Objective To study the compound propofol sevoflurane antihypertensive effect of surgery for aneurysms interventional embolization of controlling. Methods Select our hospital from February 2014 to February 2015 aneurysms in patients treated 60 cases. It can be divided into observation group and control group, 30 cases each. Observation group inhaled sevoflurane composite propofol, control group inhaled sevoflurane. SpO2 and HR, MAP, ECG were observed and recorded the body the concentration of sevoflurane, anesthetic duration, extubation time, low blood pressure, incidence of postoperative agitation syndrome. Results Two groups of patients with SpO2, HR, MAP, the anesthetic duration, extubation time had no significant difference; Observation group of patients in the concentration of sevoflurane, low blood pressure and postoperative agitation disease incidence rate is lower than the control group. Conclusion Sevoflurane composite propofol used in the aneurysm interventional embolization in controlling antihypertensive effect is good, is worth promoting in clinical.

关 键 词:七氟烷 丙泊酚 控制性降压 动脉瘤介入栓塞手术 

分 类 号:R614[医药卫生—麻醉学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象